Liu, Zhaoyun et al. innovatively demonstrated the enhanced immunogenic cell death therapy of nanomedicine, confirming that loading aggregation-induced emission photosensitizers into nanoparticles of bovine serum albumin (BSA/TPA-Erdn) can activate T cells, reverse T cell senescence, and recruit more functional T cells into MM tumors, thereby restoring the MM microenvironment and finding new directions for MM treatment [108]. This evidence concerns the gene ALB and Miyoshi myopathy.